Fresenius Ventures
Corporate venture capital fund of Fresenius SE & Co. KGaA
Corporate venture fund set up by Fresenius (Bad Homburg) in July 2026 to invest more than €200m over five years, early stage to growth, in fields adjacent to (Bio)Pharma, MedTech and care.
Corporate venture fund of Fresenius SE & Co. KGaA, launched July 2026. Separate from the older venture unit of Fresenius Medical Care.
- HEADQUARTERS
- Bad Homburg, Germany
- FOUNDED
- 2026
- AUM
- —
- OUTSIDE CAPITAL
- No — own capital only
- TEAM LISTED
- 1 people
Focus
- STAGES
- SeedSeries ASeries BGrowth
- ASSET MIX
- Venture capitalDirect investments
- GEOGRAPHY
- Global
Overview
Fresenius Ventures is the corporate venture capital fund that Fresenius SE & Co. KGaA announced on 23 July 2026. It invests in founders, technologies and business models from early financing rounds to growth stage, with an intended investment volume of more than €200 million over the next five years, in growth fields adjacent to Fresenius' platforms (Bio)Pharma, MedTech and Care Provision. Named example areas are precision nutrition, microbiome research, new modalities and digital care provision. It is led by Dr. Thomas Michael Thestrup, who joined from Angelini Ventures.
Investment thesis
Invest in healthcare innovators adjacent to Fresenius' strategic platforms (Bio)Pharma, MedTech and Care Provision, e.g. precision nutrition, microbiome research, new modalities and digital care provision, combining capital with medical, regulatory and operational expertise and access to clinical, scientific and academic networks.
People
- Dr. Thomas Michael ThestrupManaging Director and Head of Fresenius Ventures · source
Links
Frequently asked questions
Fresenius Ventures is a corporate venture arm based in Bad Homburg, Germany, founded in 2026.
Yes. Fresenius Ventures invests its own capital in private companies.
Fresenius Ventures invests at Seed, Series A, Series B and Growth stages in HealthTech, Biotech & Life Sciences and Food & Agriculture.
Key people at Fresenius Ventures include Dr. Thomas Michael Thestrup (Managing Director and Head of Fresenius Ventures).
No. Fresenius Ventures invests its own capital and does not raise money from outside investors.